Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review
about
The treatment of traumatic brain injury with velcade.Minimal residual disease following allogeneic hematopoietic stem cell transplantation.Cellular immunotherapy for plasma cell myeloma.Therapeutic benefits targeting B-cells in chronic graft-versus-host disease.Novel N-amidinopiperidine-based proteasome inhibitor preserves dendritic cell functionality and rescues their Th1-polarizing capacity in Ramos-conditioned tumor environment.Bortezomib: a new player in pre- and post-transplant desensitization?
P2860
Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review
@ast
Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review
@en
type
label
Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review
@ast
Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review
@en
prefLabel
Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review
@ast
Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review
@en
P2093
P2860
P1476
Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review
@en
P2093
Edwin P Alyea
John Koreth
Lisbeth A Welniak
William J Murphy
P2860
P304
P356
10.1016/J.BBMT.2009.07.016
P577
2009-12-01T00:00:00Z